{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-061237","form_type":"8-K","ticker":"HRMY","cik":"0001802665","company_name":"Harmony Biosciences Holdings, Inc.","filed_at":"2026-05-14T20:31:08+00:00","discovered_at":"2026-05-14T20:32:00.297984+00:00","generated_at":"2026-05-14T20:32:59.802209+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Harmony Biosciences shareholders elect four directors, ratify auditor, approve say-on-pay at 2026 annual meeting","bullets":["All four Class III director nominees elected: Geno Germano (44.96M for), Troy Ignelzi (32.81M), Ron Philip (31.83M), Andreas Wicki (25.11M).","Deloitte & Touche ratified as independent auditor for FY2026 with 49.39M for, 0.83M against, 0.17M abstain.","Say-on-pay advisory vote approved: 33.25M for, 13.04M against, 0.19M abstain; broker non-votes of 3.89M.","Quorum of 50.38M shares represented out of outstanding; all proposals passed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-061237","json":"https://secwatch.observer/filing/0001104659-26-061237.json","markdown":"https://secwatch.observer/filing/0001104659-26-061237.md","text":"https://secwatch.observer/filing/0001104659-26-061237.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802665/000110465926061237/0001104659-26-061237-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802665/000110465926061237/hrmy-20260514x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T20:32:59.802209+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"274b2f3ff4fba1f122b0b072a200c1c071b43d3b","claim":"Harmony Biosciences Holdings, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-14 meeting.","evidence_excerpt":"Proposal 2. The ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465926061237/0001104659-26-061237-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-14"}],"fact_type":"shareholder_vote"},{"claim_id":"a6b4ae7e06dd83c6ae7788be5030869b040bbaee","claim":"Harmony Biosciences Holdings, Inc. shareholders approved Election of four Class III directors at the 2026-05-14 meeting.","evidence_excerpt":"Proposal 1. The election of four Class III directors listed below to serve until the Company’s 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465926061237/0001104659-26-061237-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-14"}],"fact_type":"shareholder_vote"},{"claim_id":"ca211b6df6d33d8e849c379f8ab79dcef4bf5680","claim":"Harmony Biosciences Holdings, Inc. shareholders approved Approval on a non-binding, advisory basis, of the compensation of the Company’s named executive officers at the 2026-05-14 meeting.","evidence_excerpt":"Proposal 3. The approval on a non-binding, advisory basis, of the compensation of the Company’s named executive officers pursuant to the SEC’s compensation disclosure rules.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1802665/000110465926061237/0001104659-26-061237-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-14"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}